Clinical experience · Kratom and 7-OH dependence
MyStreetHealth treats kratom and 7-OH dependence as a clinical focus. The condition is real, the receptor pharmacology is well-described, and the treatment overlap with opioid use disorder is significant. Our team — led by a licensed physician — manages kratom and concentrated 7-OH dependence through telehealth visits in Virginia, West Virginia, Maryland, Washington DC, and Ohio, drawing on the published case-series literature (Wake Forest 2021, Yale 2024, Journal of Addiction Medicine case reports), FDA’s 2025 actions on concentrated 7-OH products (June 2025 warning letters; July 2025 scheduling recommendation), and our own clinical experience. Buprenorphine use for kratom or 7-OH dependence is off-label — the decision is individualized.
Dependence vs. addiction
Physical dependence is not the same as addiction — but both can happen.
Physical dependence means your body has adapted to the presence of a substance and produces withdrawal symptoms when it is reduced or stopped. Many people who use kratom daily develop physical dependence without meeting full criteria for a use disorder.
Addiction involves compulsive use despite negative consequences — continued use even when it is causing problems. Some kratom users experience this; many do not. Both dependence and addiction can be treated.
Why kratom causes dependence
Kratom acts on opioid receptors.
Kratom's primary active compounds — mitragynine and 7-hydroxymitragynine (7-OH) — bind to mu-opioid receptors in the brain. This is the same receptor system involved in opioid dependence. Regular use leads to receptor adaptation, tolerance, and ultimately withdrawal when use stops.
7-OH, which is now sold as a concentrated extract, is significantly more potent than kratom leaf and produces dependence more rapidly and more severely. See what hydro 7 (7-OH) kratom is for a detailed explanation.
Withdrawal
Kratom withdrawal is usually uncomfortable, not typically life-threatening.
Symptoms include muscle aches, irritability, anxiety, insomnia, sweating, and strong cravings. Severity depends on dose, duration, and the form of kratom used. 7-OH withdrawal is generally more intense than kratom leaf withdrawal at equivalent opioid effect levels.
Kratom withdrawal is not typically life-threatening in the way severe alcohol or benzodiazepine withdrawal can be, but it can still require medical care — especially if symptoms are severe, dehydration occurs, mental health symptoms worsen, pregnancy is involved, or other substances are being used. Many people return to using kratom to relieve withdrawal, which is what makes stopping difficult without medical support.
Treatment
Buprenorphine has been used off-label for kratom dependence.
Because kratom acts on opioid receptors, buprenorphine (Suboxone) targets the same pathway and can address withdrawal and cravings. Buprenorphine is FDA-approved for opioid use disorder, not specifically for kratom use disorder — the evidence for kratom-specific use comes from published case reports and case series, and the decision should be individualized by a clinician. Treatment is available through telehealth where clinically appropriate. MyStreetHealth provides buprenorphine treatment for kratom and 7-OH dependence in Virginia, West Virginia, Maryland, Washington DC, and Ohio.